Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Conditions: Toxic Epidermal Necrolysis Interventions: Drug: Abrocitinib Sponsors: Peng Zhang Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials